Skip to main content
FN

Forest Neurotech

Forest Neurotech develops a minimally invasive ultrasonic whole-brain computer interface that measures and modulates brain-wide neural activity using advanced ultrasound transducers and miniaturized electronics. This technology addresses imbalances in neurological and psychiatric disorders by enabling personalized understanding and treatment of brain function.

Los Angeles, United StatesFounded 2023182K+ followers
Updated 4 months ago

Funding

$14M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Neurological and psychiatric disorders stem from imbalances within brain-wide networks, yet current methods for measuring and modulating neural activity are often invasive or lack the necessary spatial resolution for personalized treatment. Existing neuroimaging techniques may not provide the real-time feedback needed to adapt therapeutics effectively.

Solution

Forest Neurotech is developing a minimally invasive ultrasonic whole-brain computer interface designed to measure and modulate brain activity across the entire brain. The implant integrates advanced ultrasound transducers and miniaturized electronics onto a single microchip, enabling neuroimaging and modulation throughout the brain. This technology aims to provide personalized understanding and treatment of neurological and psychiatric disorders by continuously monitoring brain-wide function and adapting therapeutics accordingly. The system leverages Butterfly Network’s Ultrasound-on-Chip technology.

Target Audience

The primary target audience includes individuals suffering from neurological and psychiatric disorders, as well as clinicians and researchers seeking advanced tools for understanding and treating brain function.

Features

  • Minimally-invasive implant for whole-brain neuroimaging and modulation.
  • Integrated ultrasound transducers and miniaturized electronics on a single microchip.
  • Real-time monitoring of brain-wide neural activity.
  • Personalized therapeutic adjustments based on continuous feedback.
  • Utilizes Butterfly Network’s Ultrasound-on-Chip technology.
This profile is AI-generated and may contain inaccuracies.